Brief: ZQ Capital Says Skygem & Southern Fox Agreed To Subscribe In Allergy Therapeutics At Issue Price Of 1p/Share
April 6 (Reuters) - ZQ Capital Limited:
* STATEMENT REGARDING POSSIBLE MANDATORY CASH OFFER
* SKYGEM AND SOUTHERN FOX INVESTMENTS EACH AGREED TO
CONDITIONALLY
SUBSCRIBE IN ALLERGY THERAPEUTICS AT ISSUE PRICE OF 1P/SHARE
Source text for Eikon: ID:nRSF6709Va
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update